We’re 6 Months Old!

Entering our 6th month of operations, we are excited to share an update about our offerings and growth at AIMS Institute:

Introducing our Newest Team Members

AIMS is thrilled to welcome two new members to our Patient Care Coordination team – Meaghan McKracken and Hila Dean. These ladies are multitalented, super resourceful and unwavering in their commitment to serve our patients. Here’s a bit more about them:

We’re 6 Months Old!

Meaghan McKracken joined the front of office team in January. She enjoys the dynamic care she is witness to here at AIMS and the connections grown from working with all of the amazing patients that are called to work with our clinic. On top of working with many health clinics over the years in many diverse roles, Meaghan is a Licensed Massage Therapist who has been in practice actively for 12 years. She has recently transitioned from working full-time in bodywork, to teaching massage, and now to building bodywork and massage into the AIMS Institute. Stay tuned for more as we work to bring these services and more to AIMS!

We’re 6 Months Old!

Hila, psychonaut and neuroqueer human, joined us just a few short weeks ago. When she is not helping AIMS patients, she is studying therapeutic & spiritual use of psychotropics for the purpose of optimal daily life experience. This pursuit will continue in the fall, when she attends the California Institute of Integral Studies (CIIS). Hila is also a recovery and transformational coach. She will be facilitating the AIMS Institute Psychedelic Integration group, which is open to all members of the public. She is a yogi, writer, and community organizer.

We’re adjusting IV Therapy and Ketamine-Assisted Therapy pricing

AIMS Institute is updating our Ketamine-Assisted Therapy (KAP) program and IV C Therapy pricing to more accurately reflect the value patients receive from this service as well as the real operational costs to our institute. This change is in service of the long-term health and expansion of these programs and will ensure ketamine assisted therapy and IV therapy remain at AIMS Institute for many years to come!

Starting on April 1st, KAP out-of-pocket costs will be:

We’re 6 Months Old!

* Please note that these prices reflect cost per session, not the entire 6-week track.

Starting on April 15th, IV Vitamin C out-of-pocket costs will be:

We’re 6 Months Old!

* Please note that these prices reflect the cost for the entire 6-week track.

Keeping our services accessible to our beloved community is not just a slogan for us–it’s what makes AIMS, AIMS! If cost is a concern from you, please note that we offer low-dose ketamine sessions with our psychotherapy team starting at $50 and have low-interest payment plans available. Patients with ketamine lozenge prescriptions may use them with our therapy team free of charge.

Have any questions or concerns? Feel free to reach out and we will get back to you quickly.

Phone: 206-420-1321 x 1

Fax: 833-584-0067

Email: info@aimsinstitute.net

Public Psychedelic Integration Group
Our newest team member, Hila Dean, will be facilitating a Psychedelic Integration Group. This group is open to the public and is an opportunity to connect with others working with psychedelic medicines in their healing journey. At AIMS we believe that the lifelong work of integration—the process of making meaning from information gained through work with psychedelic medicines—is greatly enhanced by processing together with others. To RSVP and find more information, click here.

What: Psychedelic Integration Group

When: April 24th 7:00-9:00 pm (and every other Wednesday evening going forthcoming)

Where: AIMS Institute (2825 Eastlake Ave E STE 115 Seattle, WA 98102)

Cost: $20

Give us a Call!
We would love to hear from you if you have questions, bold ideas, or if you’d like to make an appointment. Thank you for your support and for your collaboration in our dogged pursuit of integrative health!

In health,

The AIMS Team

Phone: 206-420-1321 x 1

Fax: 833-584-0067

Advanced Integrative Medical Science Institute
Advancing integrative medical care and research in oncology, psychiatry, neurology, rehabilitation, pain, and palliative care

2825 Eastlake Ave E, #115,

Seattle, WA 98102

Latest Blog Posts

Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

https://scholarworks.seattleu.edu/dnp-projects/166/ The prevalences of Post-Traumatic Stress Disorder (PTSD), generalized anxiety disorder (GAD), and major depressive disorder (MDD) have risen significantly in recent years, particularly following the COVID-19 pandemic. Many individuals remain symptomatic despite conventional treatments, highlighting the need for novel, integrative interventions. Stellate Ganglion Block (SGB), a procedure targeting the cervical sympathetic chain to modulate the autonomic nervous system, has emerged as a promising therapy for treatment-resistant psychiatric symptoms. Evaluating data from the PTSD Checklist for DSM-5 (PCL-5), Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9), this retrospective study examined the clinical outcomes of PTSD, anxiety, and depression symptoms ...

Read More
BEWARE OF CANCER MISINFORMATION

BEWARE OF CANCER MISINFORMATION

Our AIMS Institute oncology team is well informed about alternative cancer therapies such as ivermectin, intravenous vitamin C, mistletoe, curcumin, and mebendazole.  We help our patients sort through marketing hype, wishful thinking, and the real value of some alternative treatments. We say to our cancer patients who do not trust conventional medicine to beware of misinformation on the internet.  Be discerning.  We can help. Here is a recent MEDSCAPE article on this topic. ...

Read More
AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

LJ STANDISH AND DAVID JAMES Dr. Standish and her team can help improve brain function, improve memory and slow cognitive decline in Alzheimer’s disease.  Please make an appointment to start.  Call 206-420-1321.  Scientific Rationale A protocol incorporating low-dose lithium orotate, Lion’s Mane mushroom extract, NADH, transcranial magnetic stimulation (TMS), and blood sugar regulation counseling is scientifically rational for treating cognitive decline based on mechanistic, preclinical, and emerging human studies. Low-Dose Lithium Orotate (5 mg/day) Recent brain tissue studies link low brain lithium to the onset and progression of Alzheimer’s disease, with deficiency accelerating synaptic loss and cognitive decline. Low-dose lithium orotate has ...

Read More
Call Us Text Us
Skip to content